Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
* Required Fields
Pay by invoice
With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgen’s blinatumomab (Blincyto®) and Chugai’s Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations of monoclonal antibodies, which can only bind to a single epitope. Bispecific antibodies represent a highly promising class of therapeutics and were conceptualized more than 5 decades ago, but challenges associated with protein engineering, immunogenicity, stability, and manufacturing have dampened their commercialization. Bispecific antibodies (bispecifics) are considered as the next gen antibody therapeutics, which could be used in cancer treatment for better cytotoxic effects, and also hold promise for certain therapeutic applications ,which are complex and refractory to other modalities, such as immune cell retargeting, site-specific targeting, and CNS targeting. With several advanced antibody engineering technologies in place- bispecific antibodies are demonstrating a high potential to transform cancer immunotherapy landscape, and also bring about a significant change in the treatment of infectious diseases and autoimmune diseases. This Frost Radar™ profiles companies (excluding Tier 1 pharma/biopharma companies), which are highly innovative and primed for growth in the near term. It has excluded companies, which have candidates in pre-clinical/phase 1 development, and is focused on companies, which would have a near term commercial realization.
INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, ADVANCED DIAGNOSTICS, AND DIGITAL THERAPY PLATFORMS
GROWTH OPPORTUNITIES IN TARGETED CANCER THERAPY & CANCER DIAGNOSTICS, VIRAL VECTORS, MULTIPLE DISEASES, RETINAL DISEASES, AND COSMECEUTICALS
Transformational Growth Powering the Digital Operating Room Market in the United States and Western Europe
INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, POINT-OF CARE DIAGNOSTICS, AND NOVEL IMPLANT PLATFORMS
Artificial Intelligence Powering the Global Medical Imaging Market
GROWTH OPPORTUNITIES IN GENE THERAPIES, CANCER, DISEASE TREATMENT & MONITORING, SURGICAL APPLICATIONS AND COSMETICS
Innovations and Growth Opportunities in Surgical Robots, Mental Health Therapeutic Devices and Novel Diagnostic and Monitoring Devices
COVID-19 Pandemic and Rising Prevalence of Respiratory Disorders Catapult Growth in Global Extracorporeal Membrane Oxygenation (ECMO) Market
Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care
GROWTH OPPORTUNITIES IN GENE THERAPIES FOR RARE GENETIC DISORDERS, DRUG DELIVERY THERAPIES, ANTIBIOTICS, AND COVID-19 VACCINES
consumer drone market
solar cell market
alternative energy market
heavy commercial vehicles market
renewable energy market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.